EE429 Estimation of Utility Weights for Patients With Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) Previously Treated with a Covalent Bruton Kinase Inhibitor (cBTKi)
Abstract
Authors
Ehsan Masoudi Min-Hua Jen Christopher Graham Amanda Erbe Peter Maguire Kaisa-Leena Taipale Carol Qiao Ziwei Zhang Yimei Han Peita Graham-Clarke